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Gingival infection is one of most important and frequent disease among oral 
inflammation in dogs (Harvey, 1998). Actually, sufficient data exist to sustain the 
intervention of immune mechanisms in evolution of gingival diseases (Preshaw et al., 2004), 
but the usefulness of immune therapy is unclear (Page, 2000). Despite this controversy, the 
utility of diverse immune-modulator products have practical support and popularity in the 
human stomatology. These aspects lead to the need of rethinking the gingival therapy. 
The aim of this study was to monitor the clinical effects of the immune-modulating 
therapy (staphylococcal bacterine) in dog gingivitis. The study used a non-homogeny group 
formed by 4 dogs. The Oral Hygiene Index (OHI), Russel Periodontal Index (RPI), Dental 
Mobility Index (DM), Fuchs Bone Index (FBI), Periodontal Pocket Depth (PPD) were 
determined for each animal. With a complex bacteriological methodology we evaluated the 
participation and the importance of the Staphylococcus spp. for the pathology of the gingival 
diseases. The immune modulation with staphylococcal antigens was realized in all four dogs 
with gingival inflammation. The administration of staphylococcal bacterine was effectuate 
subcutaneously 7 times, in 5-7 days interval (alternating left and right thoracic region) in 
increasing dose (0,1 – 1 ml):  
From the investigated cases we isolated six Staphylococcus spp. strains 
(Staphylococcus intermedius (n=2), S. epidermidis (n=2), S. hycus (n=1) şi S. hominis (n=1)). 
Further, from these strains used an original inactivation method was obtained six various 
staphylococcal bacterine.  
The immune stimulatory effect of staphylococcal bacterine become observable after the 
fifth inoculation (fourth week of therapy) (perfect likeness with results obtained by Georgescu, 
2004). Corroborating the results from all four animals respecting the immune stimulatory 
therapy, we can affirm that the OHI index (oral hygiene index) in all cases has reduced.  
This result is in concordance with others (Georgescu, 2004) who applied 
staphylococcal products in therapy of human human inflammation, suggesting that the 
immune therapy with staphylococcal lyzate is an efficient, low cost complementary 
therapeutic method in dogs.  
 
